FLT3 and leukemia: In line with the importance of CAMs in drug-resistance and the interplay of leukemia cells with the bone marrow niche, resistant cells showed significantly altered migration and adhesion properties, and both LPXN and PTK2B were upregulated in LSCs of FLT3-mutated patients.